<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04825353</url>
  </required_header>
  <id_info>
    <org_study_id>IDIRB2017122601-268</org_study_id>
    <nct_id>NCT04825353</nct_id>
  </id_info>
  <brief_title>Endoscopic Guided PCNL Versus Standard PCNL</brief_title>
  <official_title>Endoscopic Combined Intrarenal Surgery for Management of Large Renal Stones: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      currently, percutaneous nephrolithotomy (PCNL) is the standard procedure of choice for&#xD;
      management of large renal more than 2 cm.&#xD;
&#xD;
      the pivotal step in performing PCNL is creation of proper tract. this step can be done&#xD;
      monitored under guidance of different modalities such as fluoroscopy, ultrasonography,&#xD;
      endoscopy or combined in ECIRS, tract creation is controlled under endoscopic vision with a&#xD;
      flexible ureteroscope .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: compare safety and efficacy and adverse events of ECIRS in comparison of standard&#xD;
      fluoroscopic guided PCNL.&#xD;
&#xD;
      patients &amp; methods: Patients will randomly be divided into two equal groups:&#xD;
&#xD;
      Group A: Patient will undergo ECIRS.&#xD;
&#xD;
      Group B: Patient will undergo standard PCNL&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone Free Rate</measure>
    <time_frame>1day after operation.</time_frame>
    <description>If their is any residual stones</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stone Free Rate</measure>
    <time_frame>1 months post operative</time_frame>
    <description>If their is any residual stones</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stone Free Rate</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>If their is any residual stones</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>operative time</measure>
    <time_frame>intra oprative</time_frame>
    <description>the length of operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood loss</measure>
    <time_frame>pre-operative and 1 day post-oprative</time_frame>
    <description>hemoglobin drop</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stones, Kidney</condition>
  <arm_group>
    <arm_group_label>ECIRS-Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SPCNL-GRoup</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic compbined guided PCNL</intervention_name>
    <description>patient undergo stone removal by ECIRS</description>
    <arm_group_label>ECIRS-Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard PCNL</intervention_name>
    <description>patient undergo SPCNL</description>
    <arm_group_label>SPCNL-GRoup</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with renal stones diameter of at least 2 cm.&#xD;
&#xD;
          -  American Society of Anesthesiology score ≤ 2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with renal anomalies.&#xD;
&#xD;
          -  transplanted kidney.&#xD;
&#xD;
          -  uncorrected coagulopathy.&#xD;
&#xD;
          -  active infection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Waleed El-Shaer, M.D</last_name>
    <phone>01015767331</phone>
    <phone_ext>0020</phone_ext>
    <email>waleed_elshaer@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banha university hospital</name>
      <address>
        <city>Banhā</city>
        <state>Qalubia</state>
        <zip>13511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Waleed El-Shaer, MD</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

